Adam Esbenshade is an Oncology physician affiliated with Monroe Carell Jr. Children's Hospital. OpenAlex indexes 89 publications with 1,874 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
397 Prb 2220 Pierce Ave
Nashville, TN 372320001
Telephone
615-936-1762Provider last certified this registry record 25 Mar 2022.
Clinical trials
- ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients
Sponsor: Vanderbilt-Ingram Cancer Center
- Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Sponsor: Vanderbilt University
- Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission
Sponsor: Vanderbilt University Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Natasha Halasa, MD
Monroe Carell Jr. Children's Hospital
John Wellons, MD
Monroe Carell Jr. Children's Hospital
Steven Webber, MD
Monroe Carell Jr. Children's Hospital
Lori Jordan, MD
Monroe Carell Jr. Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”